Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review.
Chan JL, Murphy KA, Sarna JR.
J Neurol. 2021 Oct;268(10):3517-3548. doi: 10.1007/s00415-021-10458-0. Epub 2021 Feb 22.
Autoimmune Movement Disorders.
Balint B.
Continuum (Minneap Minn). 2024 Aug 1;30(4):1088-1109. doi: 10.1212/CON.0000000000001455.
Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome.
Desai J, Mitchell WG.
J Child Neurol. 2012 Nov;27(11):1482-8. doi: 10.1177/0883073812450318. Epub 2012 Jul 17.
Post COVID Acute Cerebellar Ataxia and Myoclonus (ACAM).
Maramattom BV, Santhamma SGN.
Ann Indian Acad Neurol. 2022 Sep-Oct;25(5):948-950. doi: 10.4103/aian.aian_187_22. Epub 2022 Oct 31.
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
Mitoma H, Manto M, Hampe CS.
Curr Neuropharmacol. 2019;17(1):33-58. doi: 10.2174/1570159X16666180917105033.
Myoclonus and Cerebellar Ataxia Following COVID-19.
Dijkstra F, Van den Bossche T, Willekens B, Cras P, Crosiers D.
Mov Disord Clin Pract. 2020 Sep 28;7(8):974-976. doi: 10.1002/mdc3.13049. eCollection 2020 Nov.
Acute Cerebellar Ataxia and Myoclonus in SARS-CoV-2-Related Encephalopathy Responsive to Immunotherapy: A Case Series.
Grazzini M, Godani M, Grisanti S, Benedetti L, Lanza G.
Mov Disord Clin Pract. 2023 Feb;10(2):343-345. doi: 10.1002/mdc3.13598. Epub 2022 Oct 29.
Stiff Person Syndrome and GAD Antibody-Spectrum Disorders.
Dalakas MC.
Continuum (Minneap Minn). 2024 Aug 1;30(4):1110-1135. doi: 10.1212/CON.0000000000001457.
Immune-mediated ataxias.
Joubert B, Rostásy K, Honnorat J.
Handb Clin Neurol. 2018;155:313-332. doi: 10.1016/B978-0-444-64189-2.00021-4.
Myoclonus and Cerebellar Ataxia Associated with SARS-CoV-2 Infection: Case Report and Review of the Literature.
Giannantoni NM, Rigamonti E, Rampolli FI, Grazioli-Gauthier L, Allali G, Vanini G.
Eur J Case Rep Intern Med. 2021 May 6;8(5):002531. doi: 10.12890/2021_002531. eCollection 2021.
